Technical indicators for Pfizer and GSK have turned bullish.
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
A trio of drugmakers are treading the boards to raise awareness of global antimicrobial resistance (AMR). Pfizer, GSK and Shionogi have all signed on to sponsor the upcoming London run of the stage ...
Pfizer held a close to 12% stake in ViiV Healthcare, a London-based pharmaceutical venture specialising in HIV and AIDS ...
In addition to Berenberg Bank, GlaxoSmithKline also received a Hold from Deutsche Bank ‘s Emmanuel Papadakis in a report issued on March 24. However, on the same day, TipRanks – Google reiterated a ...
After GSK’s Lymerix, the only Lyme disease vaccine ever approved, was pulled from the market in 2002 amid a safety ...
The logo of Shionogi & Co Ltd is displayed at their Tokyo branch office in Tokyo, Japan February 24, 2023. REUTERS/Androniki Christodoulou Jan 20 (Reuters) - Japan's Shionogi & Co said on Tuesday it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results